Molecular Basis of Rabies Virus Virulence. I. Selection of Avirulent
Mutants of the CVS Strain with Anti G Monoelonal Antibodies (.4 ccepted 3 March 1982) SUMMARY Two avirulent mutants of the CVS strain of rabies virus were isolated from clones resistant to one neutralizing monoclonal antibody. The virulence of clones resistant to three other anti-glycoprotein monoclonal antibodies was similar to that of the wild-type.
Rabies virus has very little cytopathic effect in many cell cultures or in the brains of infected animals and the mechanism of its virulence remains unclear. Alteration of neuron metabolism is suspected, possibly caused by the integration of virus proteins into cellular membranes. A dual role of the immune system which may prevent or enhance the disease has also been postulated (Prabhakar & Nathanson, 1981) . There are two basic questions concerning the problem of virulence. (i) What are the virus-induced modifications of host metabolism which are responsible for death? (ii) Which virus protein induces such modifications? The second question is difficult to answer without good avirulent mutants, i.e. mutants differing from the wild-type by a single mutation. Their frequency in a virus population is probably low, and attempts at direct isolation have been unsuccessful (no avirulent mutants among 100 clones studied) (A. Flamand & T. J. Wiktor, unpublished results). The avirulent HEP strain of rabies virus derived by multiple passages from the original Flury virulent isolate cannot be used in such a study since it has accumulated too many mutations.
The availability of neutralizing monoclonal antibodies provided us with another approach to this problem: a two-step screening procedure was devised whereby (i) glycoprotein (G) mutants of the virus could be isolated on the basis of the loss of sensitivity to an anti-G-neutralizing monoclonal antibody, and (ii) the virulence-avirulence characteristics of the mutants could be determined by intracerebral (i.e.) inoculation of adult mice. This procedure allowed us to isolate two avirulent mutants of the CVS strain of rabies virus which were named respectively AvO 1 and AvO2 (Av, avirulent; O, Orsay). Conditions of isolation and preliminary characterization of the mutants are described in this paper.
A clone-purified CVS strain propagated in BHK-21 cells (CVSB.K_21)was chosen because it is fully virulent in adult mice by i.c. inoculation at concentrations ranging from 0-1 to 106 p.f.u. Thirty-nine mutants resistant to monoclonal antibodies no. 231-22, 248-8, 507-1 or 509-6 (3, 13, 20 and 3 mutants respectively) (Flamand et al., 1980b) were selected by the method of from a 5-fluorouracil-mutagenized CVS stock, by plating survivors to neutralization on to CER cells. Mutants resistant to each monoclonal antibody were present in the virus stock with a frequency of about 10 -3. Pathogenicity of the 39 mutants was tested by i.e. inoculation of 103 p.f.u, into groups of five adult mice. The virulence of 37 mutants was similar to that of the CVS strain, death occurring between 7 and 9 days after inoculation. Two mutants had lost their virulence for adult mice; both were resistant to monoclonal antibody no. 248-8. Surviving mice resisted i.c. challenge with 40 LDs0 of a CVS stock prepared from brains of infected mice.
Concentrations of AvO1, AvO2 and CVSB.K_21 varying from 0.1 to 106 p.f.u, were injected either i.e. or intramuscularly into adult mice. Animals inoculated with AvO1 and * The reactivity of AvO 1, AvO2 and CVS towards anti-nuc|eocapsid monoclonal antibodies was measured as follows. Labtek slides of BHK-21 cells were infected with the appropriate virus at an m.o.i, of 5 or mock-infected. After 18 h incubation at 37 °C, cells were fixed with formaldehyde (25 %) for 1 h at room temperature and washed. A 10/~1 amount of anti-N hybridoma supernatant was then added. Cells were incubated for 1 h at 37 °C, washed twice with phosphate buffer (0.2 M, pH 7.2) and incubated with 10/~1 of mouse anti-IgG fluorescent antibody (Institut Pasteur Production, diluted 1/50) for 1 h at 37 °C. Preparations were washed several times with the phosphate buffer and distilled water, and then observed in a fluorescence microscope.
"~ The reactivity of AvO 1, AvO2 and CVS towards anti-glycoprotein monoclonal antibodies was determined as follows. 3 × 102 to 5 × 102 p.f.u, of the virus in 100/tl minimal essential medium + 0.1% bovine serum albumin were incubated with 10/tl of appropriate anti-G monoclonal antibody for 30 min. Survivors were plated on to confluent monolayers of CER cells. The plaques were counted after 5 days incubation at 33 °C.
~: The reactivity of HEP and its virulent derivative towards anti-nucleocapsid and anti-glycoprotein antibodies was measured by radioimmunoassay, as described in Flamand et al. (1980b) , using 200 ng of purified virus per assay.
§ AF, Street virus (all other rabies strains are fixed viruses). IP ND, Not done.
AvO2 survived (Table 1) , whereas mice inoculated with CVS died, confirming the avirulence of the mutants. Twenty-eight days after inoculation, the brains of surviving animals contained no detectable virus material when treated with fluorescent anti-nucleocapsid (anti-N) antibodies. The reactivities of AvO 1 and AvO2 towards anti-N monoclonal antibodies were compared with the reactivity of the CVS parental strain by indirect immunofluorescent staining of infected, acetone-treated BHK-21 cells. The results presented in Table 2 show that the pattern of reactivity towards anti-N antibodies was similar in the three virus strains, indicating that the two avirulent mutants possess antigenic determinants similar to the original CVS N protein. Migration of the structural proteins of AvO1, AvO2 and CVS in SDSpolyacrylamide gradient gels was also studied. No difference could be found between the three strains (data not shown). Both observations indicate that AvO 1 and AvO2 retain the general characteristics of the CVS strain. In this respect, they are quite different from HEP, the only strain of rabies virus which is avirulent in adult mice (Koprowski, 1954; Dietzschold et al., 1979; Flamand et al., 1980a) .
When the reactivity of AvO 1 and AvO2 towards 10 anti-G monoclonal antibodies was compared with that of the CVS strain, it was found that the two mutants had lost their sensitivity to 194-2 and 613-2 in addition to 248-8 ( Table 2 ). The other mutants resistant to 248-8 were still neutralized by 194-2. Whether or not they were neutralized by 613-2 was not clear since the titre of this antibody was too low to give conclusive results. All the mutants were neutralized by the serum from CVS immune mice, as expected for viruses which retained part of the CVS antigenic sites. Whether or not avirulent mutants were present among clones resistant to 194-2 is presently under investigation.
The frequency of avirulent mutants among clones resistant to monoclonal antibody no. 248-8 (2/13) is statistically different at a 95 % significance from the maximum frequency of such mutants in the initial 5-fluorouracil-mutagenized population (0/100). This suggests that the loss of virulence is associated with the change in the antigenic site(s) recognized by the monoclonal antibody. A similar situation was observed with the HEP strain of rabies virus. A virulent derivative of this strain obtained after one passage in suckling mice according to Koprowski (1954) was kindly provided by F. Clark. When the reactivity of monoclonal antibodies against avirulent and virulent HEP was compared, it was found that the virulent derivative acquired reactivity towards 248-8 and 194-2. Avirulent HEP was not recognized by these antibodies. No other differences could be detected (Table 2 ). In this case also, virus virulence seems to be associated with the region of the glycoprotein which is recognized by 248-8 and 194-2. AvO1 and AvO2 are not temperature-sensitive mutants: they multiply equally well at 33 and 38.5 °C in in vitro cell cultures (BHK-21 or CER cells) reaching a titre similar to that of the wild-type CVS strain (2 × 107 to 5 × 107 p.f.u./ml in 30 h).
Experiments in suckling mice or in vitro primary culture of neurones indicate that the virus multiplies quite efficiently in nerve cells. Preliminary data have shown that the loss of virulence is correlated with a stimulation of the immune response in the infected animals. At what level this stimulation takes place is under study. As expected, AvO 1 and AvO2 retain their virulence for suckling mice. We are also currently investigating whether avirulent mutants are present among clones of virus resistant to other neutralizing monoclonal antibodies.
We present here a suitable method for the selection of avirulent mutants of CVS using neutralizing monoclonal antibodies. Such mutants may allow a better understanding of the mechanism(s) of virus virulence. Other aspects of this finding are that (i) it opens the possibility of selecting avirulent mutants of other rabies virus strains provided they are neutralized by antibodies no. 248-8 or 194-2 (and possibly others), and (ii) the same approach may be useful with other viruses, especially those where no attenuated strains are currently available.
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